Literature DB >> 17345264

An Investigation of the Stem Bark of Bersama abyssinica.

I H Bowen1, B P Jackson, H M Motawe.   

Abstract

The barks of two subspecies of BERSAMA ABYSSINICA, subspecies ABYSSINICA and subspecies PAULLINIOIDES have been shown to contain two bufadienolides: 5beta, 14beta-dihydroxy-3,6-diacetoxy-Delta (6)-bufa-20,22-trienolide ( 1) and 3-acetoxy-14beta-hydroxy-bufa-20,22-dienolide ( 2). Three sterols : beta-sitosterol, Delta (4)-stigmasten-3alpha-ol ( 3) and 4-methyl-Delta (5,23)-stigmast-dien-3beta-ol ( 4) have also been isolated. 3 is a new compound and 3 and 4 are reported for the first time from the Melianthaceae. The presence of the xanthone mangiferin is a possible taxonomic marker for the genus within this family. Differences between the two subspecies were seen on examining the glycoside fractions. The alcoholic extracts did not exhibit any anti-tumour activity in the standard test.

Entities:  

Year:  1985        PMID: 17345264     DOI: 10.1055/s-2007-969569

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  3 in total

1.  C-Glucoside xanthone from the stem bark extract of Bersama engleriana.

Authors:  Pierre C Djemgou; Taha A Hussien; Mohamed-Elamir F Hegazy; François Ngandeu; Gilles Neguim; Pierre Tane; Abou-El-Hamd H Mohamed
Journal:  Pharmacognosy Res       Date:  2010-07

2.  Mangiferin prevents guinea pig tracheal contraction via activation of the nitric oxide-cyclic GMP pathway.

Authors:  Aline B Vieira; Luciana P Coelho; Daniella B R Insuela; Vinicius F Carvalho; Marcelo H dos Santos; Patricia Mr Silva; Marco A Martins
Journal:  PLoS One       Date:  2013-08-08       Impact factor: 3.240

3.  In vitro antibacterial and antibiotic-potentiation activities of the methanol extracts from Beilschmiedia acuta, Clausena anisata, Newbouldia laevis and Polyscias fulva against multidrug-resistant Gram-negative bacteria.

Authors:  Simplice B Tankeo; Pierre Tane; Victor Kuete
Journal:  BMC Complement Altern Med       Date:  2015-11-22       Impact factor: 3.659

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.